GANAB
Neutral alpha-glucosidase AB
Also known as: G2AN, GANAB_HUMAN, GIIA, GluII, KIAA0088
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14697
- Gene
- GANAB
- Ensembl
- ENSG00000089597
- Chromosome
- 11
- Canonical length
- 944 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Endoplasmic reticulum
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes the alpha subunit of glucosidase II and a member of the glycosyl hydrolase 31 family of proteins. The heterodimeric enzyme glucosidase II plays a role in protein folding and quality control by cleaving glucose residues from immature glycoproteins in the endoplasmic reticulum. Expression of the encoded protein is elevated in lung tumor tissue and in response to UV irradiation. Mutations in this gene cause autosomal-dominant polycystic kidney and liver disease. [provided by RefSeq, Jul 2016]
Canonical amino-acid sequenceUniProt
944 residues, UniProt reviewed canonical sequence.
>Q14697|GANAB
1 MAAVAAVAAR RRRSWASLVL AFLGVCLGIT LAVDRSNFKT CEESSFCKRQ RSIRPGLSPY
61 RALLDSLQLG PDSLTVHLIH EVTKVLLVLE LQGLQKNMTR FRIDELEPRR PRYRVPDVLV
121 ADPPIARLSV SGRDENSVEL TMAEGPYKII LTARPFRLDL LEDRSLLLSV NARGLLEFEH
181 QRAPRVSQGS KDPAEGDGAQ PEETPRDGDK PEETQGKAEK DEPGAWEETF KTHSDSKPYG
241 PMSVGLDFSL PGMEHVYGIP EHADNLRLKV TEGGEPYRLY NLDVFQYELY NPMALYGSVP
301 VLLAHNPHRD LGIFWLNAAE TWVDISSNTA GKTLFGKMMD YLQGSGETPQ TDVRWMSETG
361 IIDVFLLLGP SISDVFRQYA SLTGTQALPP LFSLGYHQSR WNYRDEADVL EVDQGFDDHN
421 LPCDVIWLDI EHADGKRYFT WDPSRFPQPR TMLERLASKR RKLVAIVDPH IKVDSGYRVH
481 EELRNLGLYV KTRDGSDYEG WCWPGSAGYP DFTNPTMRAW WANMFSYDNY EGSAPNLFVW
541 NDMNEPSVFN GPEVTMLKDA QHYGGWEHRD VHNIYGLYVH MATADGLRQR SGGMERPFVL
601 ARAFFAGSQR FGAVWTGDNT AEWDHLKISI PMCLSLGLVG LSFCGADVGG FFKNPEPELL
661 VRWYQMGAYQ PFFRAHAHLD TGRREPWLLP SQHNDIIRDA LGQRYSLLPF WYTLLYQAHR
721 EGIPVMRPLW VQYPQDVTTF NIDDQYLLGD ALLVHPVSDS GAHGVQVYLP GQGEVWYDIQ
781 SYQKHHGPQT LYLPVTLSSI PVFQRGGTIV PRWMRVRRSS ECMKDDPITL FVALSPQGTA
841 QGELFLDDGH TFNYQTRQEF LLRRFSFSGN TLVSSSADPE GHFETPIWIE RVVIIGAGKP
901 AAVVLQTKGS PESRLSFQHD PETSVLVLRK PGINVASDWS IHLRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GANAB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.21
- Highest tissue expression
- 161 nTPM
Expression across tissuesHPA
Tissue
- liver: 161 nTPM
- epididymis: 143 nTPM
- placenta: 133 nTPM
- ovary: 125 nTPM
- thyroid gland: 124 nTPM
- parathyroid gland: 123 nTPM
Single-cell type
- extravillous trophoblasts: 188 nCPM
- hepatocytes: 108 nCPM
- migrating cytotrophoblasts: 105 nCPM
- cytotrophoblasts: 103 nCPM
- syncytiotrophoblasts: 89 nCPM
- plasma cells: 88 nCPM
Immune cell
- NK-cell: 30 nTPM
- basophil: 24 nTPM
- gdT-cell: 24 nTPM
- intermediate monocyte: 23 nTPM
- MAIT T-cell: 23 nTPM
- total PBMC: 23 nTPM
Brain region
- choroid plexus: 107 nTPM
- white matter: 89 nTPM
- hypothalamus: 84 nTPM
- thalamus: 84 nTPM
- medulla oblongata: 81 nTPM
- spinal cord: 75 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GANAB.
Disease | AllUniProt
Conditions GANAB is implicated in, by any mechanism.
- Polycystic kidney disease 3 with or without polycystic liver disease (PKD3) MIM:600666
Disease | GeneticClinVar
59 pathogenic / likely-pathogenic of 633 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Polycystic kidney disease 3 with or without polycystic liver disease
- Autosomal dominant polycystic liver disease
- POLYCYSTIC KIDNEY DISEASE 3 WITH POLYCYSTIC LIVER DISEASE
- GANAB-related disorder
- Biliary tract abnormality
Disease | ImmuneIEDB
Conditions an epitope on GANAB was assayed in.
- skin melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.27
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.24
- DepMap mean gene effect
- -0.19
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- alpha-glucosidase activity
- carbohydrate binding
- RNA binding
- Glc2Man9GlcNAc2 oligosaccharide glucosidase activity
- glucan 1,3-alpha-glucosidase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Glycoside hydrolase family 31, TIM barrel domain
- Galactose mutarotase-like domain superfamily
- Glycosyl hydrolase, all-beta
- Glycoside hydrolase superfamily
- Glycoside hydrolase family 31, N-terminal domain
- Glycosyl hydrolases family 31, active site
- Glycosyl hydrolases family 31, conserved site
- Glycosyl hydrolase family 31, C-terminal domain
- Glycosyl hydrolases family 31 TIM-barrel domain
- Glycosyl hydrolase 31 N-terminal galactose mutarotase-like domain
- Glycosyl hydrolase family 31 C-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GANAB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GANAB as an antibody target. Whether an autoantibody or antibody against GANAB could matter depends on whether native GANAB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GANAB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GANAB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...